Galecto, Inc.

Historical 13F Holders

Symbol
DMRA
CUSIP
36322Q206
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 36322Q206 since 12/18/2024, newest first.

Filer % of Class Filed
BlackRock, Inc. 13G 5.1% 7/28/2026
Event 6/30/2026
Point72 Asset Management, L.P. 13G/A Amendment 1
2.0% 5/15/2026
Event 3/31/2026
Jain Global LLC 13G/A Amendment 1
0% 5/15/2026
Event 3/31/2026
Avoro Capital Advisors LLC 13G
6.3% 5/15/2026
Event 3/31/2026
Paramora Holding LLC 13G/A Amendment 1 3.4% 4/23/2026
Event 2/9/2026
Paragon Therapeutics, Inc. 13G/A Amendment 1 3.4% 4/23/2026
Event 2/9/2026
Venrock Healthcare Capital Partners III, L.P. 13G
6.0% 2/17/2026
Event 2/9/2026
Jain Global LLC 13G
7.5% 2/17/2026
Event 12/31/2025
Fairmount Funds Management LLC 13D/A Amendment 1
20.0% 2/11/2026
Event 2/9/2026
Paramora Holding LLC 13G 7.5% 1/12/2026
Event 11/10/2025
Paragon Therapeutics, Inc. 13G 7.5% 1/12/2026
Event 11/10/2025
FMR LLC 13G
15.0% 12/5/2025
Event 11/28/2025
Fairmount Funds Management LLC 13D
20.0% 11/17/2025
Event 11/10/2025
Point72 Asset Management, L.P. 13G
6.3% 11/13/2025
Event 11/12/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 104 65.9 M $1.72 B
2026 Q1 66 56.1 M $1.45 B
2025 Q4 18 1.11 M $62.7 M
2025 Q3 12 170 k $633 k
2025 Q2 10 133 k $451 k
2025 Q1 12 143 k $442 k
2024 Q4 11 142 k $661 k
2024 Q3 11 129 k $1.56 M